Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening
Cheng-Lung Hsu(Chang Gung University), Wen-guey Wu(Chang Gung University), Li‐Yu Lee(Chang Gung University), Wen‐Lung Ma(Asia University), An-Chi Lin(Chang Gung University), Chun‐Cheng Lin(National Tsing Hua University), Ying-Hsu Chang(Chang Gung University), See-Tong Pang(Chang Gung University), Yung‐Chia Kuo(Linkou Chang Gung Memorial Hospital), Ting-Wei Lin(National Tsing Hua University), Huei‐Ju Ting(University of Rochester Medicine)
Cited by 6
Related Papers
Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia
|Science Translational Medicine|2017|381
Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular Carcinoma
|Gastroenterology|2008|253
Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor
|Hepatology|2008|207
Androgen Receptor Promotes Hepatitis B Virus–Induced Hepatocarcinogenesis Through Modulation of Hepatitis B Virus RNA Transcription
|Science Translational Medicine|2010|198
Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis
|Endocrine Related Cancer|2014|188